全文获取类型
收费全文 | 2358篇 |
免费 | 95篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 38篇 |
妇产科学 | 22篇 |
基础医学 | 362篇 |
口腔科学 | 16篇 |
临床医学 | 150篇 |
内科学 | 663篇 |
皮肤病学 | 88篇 |
神经病学 | 239篇 |
特种医学 | 100篇 |
外科学 | 406篇 |
综合类 | 18篇 |
一般理论 | 3篇 |
预防医学 | 125篇 |
眼科学 | 26篇 |
药学 | 94篇 |
肿瘤学 | 86篇 |
出版年
2023年 | 13篇 |
2022年 | 15篇 |
2021年 | 39篇 |
2020年 | 34篇 |
2019年 | 31篇 |
2018年 | 44篇 |
2017年 | 31篇 |
2016年 | 41篇 |
2015年 | 33篇 |
2014年 | 60篇 |
2013年 | 83篇 |
2012年 | 127篇 |
2011年 | 161篇 |
2010年 | 78篇 |
2009年 | 89篇 |
2008年 | 130篇 |
2007年 | 181篇 |
2006年 | 153篇 |
2005年 | 151篇 |
2004年 | 120篇 |
2003年 | 81篇 |
2002年 | 98篇 |
2001年 | 22篇 |
2000年 | 25篇 |
1999年 | 26篇 |
1998年 | 25篇 |
1997年 | 10篇 |
1996年 | 19篇 |
1995年 | 21篇 |
1994年 | 24篇 |
1993年 | 12篇 |
1989年 | 10篇 |
1978年 | 9篇 |
1960年 | 10篇 |
1958年 | 9篇 |
1943年 | 9篇 |
1939年 | 8篇 |
1936年 | 10篇 |
1935年 | 8篇 |
1933年 | 13篇 |
1932年 | 12篇 |
1931年 | 11篇 |
1930年 | 9篇 |
1929年 | 10篇 |
1928年 | 9篇 |
1927年 | 15篇 |
1926年 | 13篇 |
1925年 | 15篇 |
1924年 | 14篇 |
1911年 | 11篇 |
排序方式: 共有2455条查询结果,搜索用时 15 毫秒
91.
92.
93.
Ferdinand Mühlbacher Hans‐Helmut Neumayer Domingo del Castillo Sergio Stefoni Klemens Budde the European Rapamune Cyclosporine Minimization Study Group 《Transplant international》2014,27(2):176-186
This study evaluated the safety and efficacy of a sirolimus, corticosteroid, and cyclosporine reduction regimen in an open‐label, 12‐month trial of 420 de novo renal allograft recipients at 49 European transplant centers. One month post‐transplantation, 357 patients were randomized to receive standard‐dose cyclosporine (sCsA, n = 179) or reduced‐dose cyclosporine (rCsA, n = 178). All patients also received sirolimus and corticosteroids. The primary end points were the rate of biopsy‐confirmed acute rejection (BCAR) and renal function, as measured by serum creatinine. Baseline demographic and donor characteristics were similar between groups. BCAR rates at 12 months were not significantly different: 11.2% for rCsA patients and 16.2% for sCsA patients. Mean serum creatinine (±SEM) was significantly lower (1.75 ± 0.10 vs. 1.97 ± 0.07 mg/dl, P < 0.001), and creatinine clearance (±SEM; Nankivell method) was significantly higher (57.8 ± 1.78 vs. 49.5 ± 2.46 ml/min, P < 0.001) in patients receiving rCsA versus sCsA at 1 year, respectively. Patient and graft survival exceeded 98% in both groups. No significant differences in infection or malignancy were noted between groups. The rCsA with sirolimus and corticosteroid regimen resulted in excellent 12‐month patient and graft survival, a low incidence of BCAR, and improved renal function in renal allograft recipients. Sirolimus administered with rCsA and corticosteroids provided adequate immunosuppression while reducing the potential for the nephrotoxic effects of cyclosporine. These findings may help to improve long‐term renal allograft outcomes. 相似文献
94.
95.
96.
97.
Zeitschrift für Psychodrama und Soziometrie - In diesem Beitrag in der Zeitschrift für Psychodrama und Soziometrie wird gezeigt, dass sich grundlegende Bestimmungen des Spiels, die... 相似文献
98.
Eszter Maurovich‐Horvat David Kemlink Birgit Högl Birgit Frauscher Laura Ehrmann Peter Geisler Katharina Ettenhuber Geert Mayer Rosa Peraita‐Adrados Elena Calvo Gert Jan Lammers Astrid Van der Heide Luigi Ferini‐Strambi Giuseppe Plazzi Francesca Poli Yves Dauvilliers Poul Jennum Helle Leonthin Johannes Mathis Aleksandra Wierzbicka Francisco J. Puertas Pierre A. Beitinger Isabelle Arnulf Renata L. Riha Maria Tormášiová Jana Slonková Sona Nevšímalová Karel Šonka the European Narcolepsy Network 《Journal of sleep research》2013,22(5):496-512
In a retrospective cohort study undertaken in 12 European countries, 249 female narcoleptic patients with cataplexy (n = 216) and without cataplexy (n = 33) completed a self‐administrated questionnaire regarding pregnancy and childbirth. The cohort was divided further into patients whose symptoms of narcolepsy started before or during pregnancy (308 pregnancies) and those in whom the first symptoms of narcolepsy appeared after delivery (106 pregnancies). Patients with narcolepsy during pregnancy were older during their first pregnancy (P < 0.001) and had a higher body mass index (BMI) prior to pregnancy (P < 0.01). Weight gain during pregnancy was higher in narcoleptic patients with cataplexy (P < 0.01). More patients with narcolepsy–cataplexy during pregnancy had impaired glucose metabolism and anaemia. Three patients experienced cataplexy during delivery. The rate of caesarean sections was higher in the narcolepsy–cataplexy group compared to the narcolepsy group (P < 0.05). The mean birth weight and gestational age of neonates were within the normal range and did not differ across groups. Neonatal care was affected adversely by symptoms of narcolepsy in 60.1% of those with narcolepsy during pregnancy. This study reports more obstetric complications in patients with narcolepsy–cataplexy during pregnancy; however, these were not severe. This group also had a higher BMI and higher incidence of impaired glucose metabolism during pregnancy. Caesarian section was conducted more frequently in narcolepsy–cataplexy patients, despite cataplexy being a rare event during delivery. Furthermore, symptoms of narcolepsy may render care of the infant more difficult. 相似文献
99.
Frauke Bataille Sabine Troppmann Frank Klebl Gerhard Rogler Benjamin Stoelcker Ferdinand Hofstadter Anja-Katrin Bosserhoff Petra Rümmele 《Applied immunohistochemistry & molecular morphology》2006,14(2):225-228
Immunohistochemical techniques have gained increasing importance in diagnostics and research. While formalin-fixed, paraffin-embedded human tissue retains excellent morphology, the detection of antigens by immunofluorescence in its sections and especially the demonstration of multiple simultaneous antibodies have limitations. Double immunofluorescence labeling of routinely processed paraffin sections has been described previously. The signal intensity observed after triple labeling has been reported to be significantly inferior to that obtained by application of double fluorochromes. The authors show multicolor labeling of three and four primary antibodies in routinely processed paraffin-embedded tissue sections using a standardized immunofluorescence technique. In addition, procedures to reduce background staining and to avoid nonspecific double staining are described. 相似文献
100.
Lottner C Schwarz S Diermeier S Hartmann A Knuechel R Hofstaedter F Brockhoff G 《The Journal of pathology》2005,205(5):577-584
The determination of HER2/neu status in breast carcinomas has become essential for the selection of breast cancer patients for Herceptin therapy. Herceptin treatment is used in patients with metastatic breast carcinoma with HER2/neu protein overexpression detected by immunohistochemistry (IHC) or gene amplification analysed by fluorescence in situ hybridization (FISH). A multiparametric fluorescent approach based on the simultaneous detection of HER2/neu gene amplification and protein expression was established to increase the accuracy, and to improve the reproducibility, of HER2/neu diagnostics. Based on four paraffin-embedded breast cancer cell lines, a combined fluorescent immunostaining (FIHC) and FISH method was developed by using the PathVysion HER2 DNA Probe Kit (VYSIS) and the polyclonal antibody from the HercepTest (DAKO). Diagnostic applicability was documented on 215 formalin-fixed primary breast carcinomas. Criteria for immunofluorescence quantification were chosen by analogy with the FDA-approved HercepTest scoring, ranging from 0 to 3+. There was 97.7% concordance between conventional IHC and fluorescence IHC. The FISH data resulting from the multiparametric approach did not differ from conventional FISH. Breast carcinomas with HER2/neu protein overexpression and simultaneous gene amplification were detected with 100% sensitivity. In addition, five of the 215 cases (2.3%) had HER2/neu gene amplification without protein overexpression. The main advantage of this novel approach is that polysomy, aneuploidy, gene amplification, and protein content can be analysed simultaneously in the same cell. 相似文献